CN Patent
CN106905320A — 一种适合药用的依鲁替尼及其制剂
Assigned to HANGZHOU RONGLI MEDICINE SCIENCE & TECHNOLOGY Co Ltd · Expires 2017-06-30 · 9y expired
What this patent protects
本发明提供一种适合药用的依鲁替尼及其制剂。所述依鲁替尼杂质含量低,因而药物安全性更高。本发明的依鲁替尼制备工艺简单,成本低廉,对药物的优化和开发具有重要价值。
USPTO Abstract
本发明提供一种适合药用的依鲁替尼及其制剂。所述依鲁替尼杂质含量低,因而药物安全性更高。本发明的依鲁替尼制备工艺简单,成本低廉,对药物的优化和开发具有重要价值。
Drugs covered by this patent
- Imbruvica (ibrutinib) · AbbVie
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.